1702 related articles for article (PubMed ID: 24246731)
21. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
22. Pharmacophore assessment through 3-D QSAR: evaluation of the predictive ability on new derivatives by the application on a series of antitubercular agents.
Friggeri L; Ballante F; Ragno R; Musmuca I; De Vita D; Manetti F; Biava M; Scipione L; Di Santo R; Costi R; Feroci M; Tortorella S
J Chem Inf Model; 2013 Jun; 53(6):1463-74. PubMed ID: 23617317
[TBL] [Abstract][Full Text] [Related]
23. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
24. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
25. ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines.
Saxena AK; Alam M
Curr Top Med Chem; 2020; 20(29):2723-2734. PubMed ID: 32885753
[TBL] [Abstract][Full Text] [Related]
26. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides.
Chikhale R; Menghani S; Babu R; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
Eur J Med Chem; 2015; 96():30-46. PubMed ID: 25874329
[TBL] [Abstract][Full Text] [Related]
27. Prediction of cytotoxicity data (CC(50)) of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives by artificial neural network trained with Levenberg-Marquardt algorithm.
Arab Chamjangali M; Beglari M; Bagherian G
J Mol Graph Model; 2007 Jul; 26(1):360-7. PubMed ID: 17350867
[TBL] [Abstract][Full Text] [Related]
28. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
Raja S; Prakash CR
Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
30. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
Fatemi MH; Heidari A; Gharaghani S
J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
[TBL] [Abstract][Full Text] [Related]
31. QSAR study of heparanase inhibitors activity using artificial neural networks and Levenberg-Marquardt algorithm.
Jalali-Heravi M; Asadollahi-Baboli M; Shahbazikhah P
Eur J Med Chem; 2008 Mar; 43(3):548-56. PubMed ID: 17602800
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationships on purine and 2,3-dihydropurine derivatives as antitubercular agents: a data mining approach.
Pietra D; Imbriani M; Borghini A; Giorgi I; Settimo FD; Breschi MC; Campa M; Batoni G; Brancatisano FL; Bianucci AM
Chem Biol Drug Des; 2011 Oct; 78(4):718-24. PubMed ID: 21756283
[TBL] [Abstract][Full Text] [Related]
33. Wavelet neural network modeling in QSPR for prediction of solubility of 25 anthraquinone dyes at different temperatures and pressures in supercritical carbon dioxide.
Tabaraki R; Khayamian T; Ensafi AA
J Mol Graph Model; 2006 Sep; 25(1):46-54. PubMed ID: 16337156
[TBL] [Abstract][Full Text] [Related]
34. Antimycobacterial activity of chiral aminoalcohols with camphane scaffold.
Petkova Z; Valcheva V; Momekov G; Petrov P; Dimitrov V; Doytchinova I; Stavrakov G; Stoyanova M
Eur J Med Chem; 2014 Jun; 81():150-7. PubMed ID: 24836067
[TBL] [Abstract][Full Text] [Related]
35. Four hydrazide compounds that inhibit the growth of mycobacterium tuberculosis.
Bartzatt R; Cirillo SL; Cirillo JD
Physiol Chem Phys Med NMR; 2008; 40():55-65. PubMed ID: 20070040
[TBL] [Abstract][Full Text] [Related]
36. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Onajole OK; Pieroni M; Tipparaju SK; Lun S; Stec J; Chen G; Gunosewoyo H; Guo H; Ammerman NC; Bishai WR; Kozikowski AP
J Med Chem; 2013 May; 56(10):4093-103. PubMed ID: 23611124
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
[TBL] [Abstract][Full Text] [Related]
38. Application of quantitative structure-activity relationships to the modeling of antitubercular compounds. 1. The hydrazide family.
Ventura C; Martins F
J Med Chem; 2008 Feb; 51(3):612-24. PubMed ID: 18176999
[TBL] [Abstract][Full Text] [Related]
39. Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies.
Ragno R; Marshall GR; Di Santo R; Costi R; Massa S; Rompei R; Artico M
Bioorg Med Chem; 2000 Jun; 8(6):1423-32. PubMed ID: 10896119
[TBL] [Abstract][Full Text] [Related]
40. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
